Medical Weight Loss: Is Tirzepatide or Retatrutide Right for You?

If you’ve struggled to lose weight despite diet and exercise, you’re not alone — and you’re not out of options. Medical weight loss with Tirzepatide and Retatrutide offers a science-backed path. Here’s what you should know.

What Are Tirzepatide and Retatrutide?

Tirzepatide is an FDA-approved dual GIP/GLP-1 medication that helps regulate appetite and blood sugar by activating two incretin pathways. Retatrutide is a next-generation triple agonist — targeting GLP-1, GIP, and glucagon — prescribed off-label under close medical supervision for even greater results. Both reduce hunger and cravings, making it easier to eat less and lose weight sustainably.

Who Is a Good Candidate?

These medications may be right for you if you have stubborn weight that won’t budge, struggle with cravings, or want medically supervised support. A health evaluation determines which option is appropriate for you.

What Results Can You Expect?

Clinical studies show significant, sustained weight loss when these medications are paired with healthy habits — patients on Tirzepatide lose an average of 20–25% of body weight, with Retatrutide showing even greater results in early trials. Results vary by individual, which is why our programs are personalized and monitored.

What a Program Looks Like

• A thorough health evaluation
• A personalized medication and dosing plan
• Nutrition and lifestyle guidance
• Ongoing monitoring and adjustments

Is It Safe?

Our programs are physician-supervised. Tirzepatide is FDA-approved, and Retatrutide is prescribed off-label with close monitoring. Some patients experience mild nausea early on, which we minimize with gradual dosing.

Ready to explore your options? Book a complimentary consultation today.